Avantor, Inc. (AVTR): Price and Financial Metrics
Avantor, Inc. (AVTR)
Today's Latest Price: $24.96 USD
Updated Oct 20 7:00pm
Add AVTR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 34 in Consumer Goods
See all "A" rated Strong Buy stocks
AVTR Stock Summary
- AVTR's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.21 -- higher than only 4.45% of US-listed equities with positive expected earnings growth.
- Avantor Inc's stock had its IPO on May 17, 2019, making it an older stock than only 1.51% of US equities in our set.
- AVTR's current price/earnings ratio is 103.53, which is higher than 92.35% of US stocks with positive earnings.
- If you're looking for stocks that are quantitatively similar to Avantor Inc, a group of peers worth examining would be TSN, CAG, WPP, PRAA, and POST.
- AVTR's SEC filings can be seen here. And to visit Avantor Inc's official web site, go to www.avantorsciences.com.
AVTR Stock Price Chart Interactive Chart >
AVTR Price/Volume Stats
| Current price | $24.96 | 52-week high | $25.44 |
| Prev. close | $24.26 | 52-week low | $6.66 |
| Day low | $24.24 | Volume | 5,618,319 |
| Day high | $25.44 | Avg. volume | 4,169,381 |
| 50-day MA | $22.39 | Dividend yield | N/A |
| 200-day MA | $18.15 | Market Cap | 14.39B |
Avantor, Inc. (AVTR) Company Bio
Avantor, Inc. is a global provider of mission critical products and services. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables includes chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation includes filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services.
AVTR Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $24.96 | $1269.51 | 5133% |
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Avantor Inc. To summarize, we found that Avantor Inc ranked in the 94th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 5158.67% on a DCF basis. The most interesting components of our discounted cash flow analysis for Avantor Inc ended up being:
- Its compound free cash flow growth rate, as measured over the past 1.24 years, is 1.77% -- higher than 95.01% of stocks in our DCF forecasting set.
- As a business, Avantor Inc experienced a tax rate of about 5% over the past twelve months; relative to its sector (Basic Materials), this tax rate is higher than only 22.83% of stocks generating free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 5030% |
| 1% | 5082% |
| 2% | 5133% |
| 3% | 5184% |
| 4% | 5236% |
| 5% | 5287% |
For other companies in the Basic Materials that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as AVTR, try KRA, VEDL, FUL, BECN, and BTG.
Loading social stream, please wait...